1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 15 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2020Arrhythmia recurrence is more common in females undergoing multiple catheter ablation procedures for persistent atrial fibrillation: time to close the gender gapSugumar, H.; Nanayakkara, S.; Chieng, D.; Wong, G.R.; Parameswaran, R.; Anderson, R.D.; Al-Kaisey, A.; Nalliah, C.J.; Azzopardi, S.; Prabhu, S.; Voskoboinik, A.; Lee, G.; McLellan, A.J.; Ling, L.H.; Morton, J.B.; Kalman, J.M.; Kistler, P.M.
2021Implementation of a digital cognitive behavioral therapy for insomnia pathway in primary careSweetman, A.; Knieriemen, A.; Hoon, E.; Frank, O.; Stocks, N.; Natsky, A.; Kaambwa, B.; Vakulin, A.; Lovato, N.; Adams, R.; Lack, L.; Miller, C.B.; Espie, C.A.; McEvoy, R.D.
2021The Introduction of cPRA and Its Impact on Access to Deceased Donor Kidney Transplantation for Highly Sensitized Patients in AustraliaSypek, M.P.; Kausman, J.Y.; Watson, N.; Wyburn, K.; Holt, S.G.; Hughes, P.; Clayton, P.A.
2021Outcomes for head and neck cancer patients admitted to intensive care in Australia and New Zealand between 2000 and 2016Frauenfelder, C.A.; Raith, E.P.; Krishnan, S.; Udy, A.; Pilcher, D.
2021Update of a model to predict outcomes after endovascular aneurysm repairCowled, P.; Boult, M.; Barnes, M.; Fitridge, R.A.
2021Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trialWittert, G.; Bracken, K.; Robledo, K.P.; Grossmann, M.; Yeap, B.B.; Handelsman, D.J.; Stuckey, B.; Conway, A.; Inder, W.; McLachlan, R.; Allan, C.; Jesudason, D.; Fui, M.N.T.; Hague, W.; Jenkins, A.; Daniel, M.; Gebski, V.; Keech, A.
2022NAVKIDS² trial: a multi-centre, waitlisted randomised controlled trial of a patient navigator intervention in children with chronic kidney disease - statistical analysis plan and update to the protocolvan Zwieten, A.; Ryan, E.G.; Caldwell, P.; Howard, K.; Tong, A.; Craig, J.C.; Alexander, S.I.; Howell, M.; Teixeira-Pinto, A.; Hawley, C.M.; Jesudason, S.; Walker, A.; Mackie, F.; Kennedy, S.E.; McTaggart, S.; McCarthy, H.J.; Carter, S.A.; Kim, S.; Woodleigh, R.; Francis, A.; et al.
2022Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialMitchell, P.J.; Yan, B.; Churilov, L.; Dowling, R.J.; Bush, S.J.; Bivard, A.; Huo, X.C.; Wang, G.; Zhang, S.Y.; Ton, M.D.; Cordato, D.J.; Kleinig, T.J.; Ma, H.; Chandra, R.V.; Brown, H.; Campbell, B.C.V.; Cheung, A.K.; Steinfort, B.; Scroop, R.; Redmond, K.; et al.
2021Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: Protocol for a phase 2, randomised, double-blind, placebo-controlled trialVivash, L.; Bertram, K.L.; Malpas, C.B.; Marotta, C.; Harding, I.H.; Kolbe, S.; Fielding, J.; Clough, M.; Lewis, S.J.G.; Tisch, S.; Evans, A.H.; O'Sullivan, J.D.; Kimber, T.; Darby, D.; Churilov, L.; Law, M.; Hovens, C.M.; Velakoulis, D.; O'Brien, T.J.
2021TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosisMacKintosh, J.A.; Pietsch, M.; Lutzky, V.; Enever, D.; Bancroft, S.; Apte, S.H.; Tan, M.; Yerkovich, S.T.; Dickinson, J.L.; Pickett, H.A.; Selvadurai, H.; Grainge, C.; Goh, N.S.; Hopkins, P.; Glaspole, I.; Reynolds, P.N.; Wrobel, J.; Jaffe, A.; Corte, T.J.; Chambers, D.C.

Discover